Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

Clinical trial NCT02268695 · COMPLETED

Trial details

NCT number: NCT02268695
Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2014-10-10
Primary completion: 2021-12-31
Enrollment: 541

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.